Clinical Profile and Outcomes of Hospitalized Coronavirus Disease-2019 Patients Requiring Renal Replacement Therapy at a Tertiary Care Center

Le résumé fourni par la source

A BSTRACT Introduction: Patients with coronavirus disease-2019 (COVID-19) infection who have underlying chronic kidney disease (CKD) or experience acute kidney injury (AKI) are at an increased risk of severe disease and mortality. Materials and Methods: This single-center retrospective study was conducted at a tertiary care center offering hemodialysis (HD) facilities to COVID-19-positive patients. We included COVID-19-positive patients aged >18 years who received HD during their hospital stay. Patients were classified as CKD-5D, acute on CKD, and AKI stage-3 (AKI-3D). Results: Severe disease was seen in ~60% of patients, with a higher overall mortality (46.15%). However, there was no significant difference in mortality between CKD-5D ( n = 70), acute on CKD ( n = 32), and AKI-3D ( n = 15) groups (42.9% vs. 53.1% vs. 46.7%, P = 0.627). Advanced age, diabetic status, severe disease, and raised inflammatory markers were predictors of mortality. Conclusion: Among patients with COVID-19, severe renal disease requiring dialysis is associated with high mortality. We did not see any significant difference in mortality in either AKI or CKD subgroups.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.